Balyasny Asset Management’s AtriCure ATRC Stock Holding History

Balyasny Asset Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$494K	Buy	+17,299	New	+$590K	﹤0.01%	2370
2025 Q1	–	Sell	-76,190	Closed	-$2.33M	–	2779
2024 Q4	$2.33M	Sell	76,190 -78,730	-51%	-$2.53M	﹤0.01%	1623
2024 Q3	$4.34M	Buy	+154,920	New	+$3.82M	0.01%	1320
2023 Q3	–	Sell	-6,513	Closed	-$321K	–	2244
2023 Q2	$321K	Sell	6,513 -22,298	-77%	-$1.03M	﹤0.01%	1972
2023 Q1	$1.19M	Buy	+28,811	New	+$1.2M	﹤0.01%	1675
2022 Q2	–	Sell	-196,954	Closed	-$12.9M	–	2731
2022 Q1	$12.9M	Buy	+196,954	New	+$12.8M	0.04%	596
2021 Q4	–	Sell	-315,647	Closed	-$22M	–	2220
2021 Q3	$22M	Buy	+315,647	New	+$24.3M	0.09%	311
2021 Q1	–	Sell	-156,524	Closed	-$8.71M	–	1741
2020 Q4	$8.71M	Buy	156,524 +136,834	+695%	+$5.92M	0.05%	468
2020 Q3	$786K	Buy	+19,690	New	+$835K	0.01%	1042
2018 Q3	–	Sell	-8,174	Closed	-$221K	–	1653
2018 Q2	$221K	Sell	8,174 -7,379	-47%	-$173K	﹤0.01%	1617
2018 Q1	$319K	Buy	+15,553	New	+$281K	﹤0.01%	1593
2017 Q4	–	Sell	-10,485	Closed	-$235K	–	2047
2017 Q3	$235K	Buy	+10,485	New	+$237K	﹤0.01%	1635

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management's ATRC Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in AtriCure (ATRC) in Q1 2026: 17,299 shares worth $494K. The stake represents ﹤0.01% of the portfolio and ranks #2370 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in ATRC as recently as Q4 2024.

Balyasny Asset Management first reported a position in ATRC in Q3 2017 and has held it in 12 quarters since. The position peaked at $22M in Q3 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Balyasny Asset Management held 17,299 shares of AtriCure worth $494K as of Q1 2026.
AtriCure was a new Balyasny Asset Management position in Q1 2026.
AtriCure made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2370 holding.
Balyasny Asset Management first reported a position in AtriCure in Q3 2017 and has held it in 12 quarters since.
Balyasny Asset Management's AtriCure position peaked at $22M in Q3 2021.
223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.